Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Lifeist Wellness Inc V.LFST

Alternate Symbol(s):  LFSWF

Lifeist Wellness Inc. is a Canada-based health-tech company. The Company leverages advancements in science and technology to develop innovative products to support human wellness and transform lives. The Company's key asset is its United States biosciences subsidiary Mikra Cellular Sciences Inc. (Mikra), a biosciences and consumer wellness company focused on developing and selling products. Mikra's products consists of Focus, Protect, Serenity, and CELLF.


TSXV:LFST - Post by User

Post by whisky11on Jul 28, 2022 12:01pm
111 Views
Post# 34857226

Profitability in third quarter.

Profitability in third quarter....Labs has begun commercial scale runs of Labs-produced shatter which it expects to be in market by fiscal Q3 2022...

..
At CannMart Labs, the proprietary Roilty brand shipped to Ontario last week and is also now listed in British Columbia where it has been shipped and selling within the province..

..
Labs has begun commercial scale runs of Labs-produced shatter which it expects to be in market by fiscal Q3 2022...

..
Mikra spent the bulk of these months testing messaging and channels for scaling marketing effectively in the coming quarters while simultaneously undergoing product development and margin-increasing R&D for its flagship product, CELLF™...

.
Net cash used in operations was $7.1 million in Q2 2022 compared to $6.3 million in Q2 2021. The increase was due the business interruption at Australian Vaporizers during Q2 2022 and investments in emerging businesses including CannMart Labs and Mikra.
<< Previous
Bullboard Posts
Next >>